Dr. Glick’s presentation entitled “In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches” is scheduled Friday, June 8 at 3:45-4:15 p.m. Understanding of biochemical, biophysical, pathway and functional information is critical for decision making and hypothesis generation in drug discovery. Dr. Glick will discuss the in silico approaches to support this challenge. For example, design of bio-diverse compound libraries and intentional targeting of a specific phenotype. Dr. Glick will describe how the data should be mined and visualized to enable understanding of the molecular mechanism of action and prioritize the right chemical matter for a chemistry program.
Dr. Glick’s current research focus is the application of chemometric and systems chemical biology approaches to bridge the phenotype-target and target-lead gaps in drug discovery. Prior to that, he was a trained as postdoc in the area of computational chemistry in the University of Oxford, UK. He is the author of over 40 scientific papers in peer reviewed journals and 6 patents (see publicationslist.org/
For more details on this conference and to register, visit http://www.healthtech.com/
To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, email@example.com.
Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at firstname.lastname@example.org.
About Cambridge Healthtech Institute (www.chicorporate.com)
CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.
Cambridge Healthtech Institute